Literature DB >> 8559507

Acyclovir-associated encephalopathy, lack of relationship between acyclovir levels and symptoms.

R J de Knegt1, H van der Pijl, L A van Es.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8559507

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.

Authors:  W A Watson; N J Rhodes; I A Echenique; M P Angarone; M H Scheetz
Journal:  J Clin Pharm Ther       Date:  2017-03-29       Impact factor: 2.512

2.  Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.

Authors:  James P Smith; Stephen Weller; Benjamin Johnson; Janet Nicotera; James M Luther; David W Haas
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

3.  Coma secondary to aciclovir neurotoxicity.

Authors:  J Loughrey; P Coleman; J Donohue; B Marsh
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

4.  Varicella-zoster virus associated encephalitis in a patient undergoing haemodialysis.

Authors:  Yasser W Al-Mula Abed
Journal:  Qatar Med J       Date:  2016-01-26

5.  Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Authors:  Takuya Murakami; Tetsu Akimoto; Mari Okada; Erika Hishida; Taro Sugase; Atsushi Miki; Marina Kohara; Hiromichi Yoshizawa; Takahiro Masuda; Takahisa Kobayashi; Osamu Saito; Shigeaki Muto; Daisuke Nagata
Journal:  Drug Target Insights       Date:  2018-06-25

6.  An unexpectedly high occurrence of aciclovir-induced neuropsychiatric symptoms in patients treated for herpesvirus CNS infection: a prospective observational study.

Authors:  Johan Lindström; Anders Helldén; Jan Lycke; Anna Grahn; Marie Studahl
Journal:  J Antimicrob Chemother       Date:  2019-12-01       Impact factor: 5.790
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.